This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

South Korea designates two AI projects for regulatory sandbox program

( February 13, 2025, 07:53 GMT | Official Statement) -- MLex Summary: The South Korean government has designated four new business-development projects — including two for AI developers — to receive regulatory exceptions under a sandbox program. It will accept applications from developers to carry out the projects, and the successful applicants will be allowed to work on these projects without worrying about some regulatory obligations. The Office for Government Policy Coordination said the four include a project to develop AI programs using original CCTV video data and another to develop AI programs running on financial companies’ intranets while using services available only on outside networks. This move reflects the South Korean government’s efforts to encourage and foster AI innovation in the country by offering various advantages to private-sector developers. The statement, in Korean, is attached....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections